Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Sarcoptic mange is a debilitating disease affecting free‐living/wild bare‐nosed wombats (Vombatus ursinus). The disease causes thickening of the skin, pruritus, alopecia and deep fissures in the skin of infected animals, and ultimately death if left untreated. In Australia, there are approvals from the Australian Pesticides and Veterinary Medicines Authority to use moxidectin for treating sarcoptic mange in bare‐nosed wombats; however, few published literatures document the success of treatment regimens. Two adult male bare‐nosed wombats presented with dermatitis, erythema and crusting of the skin. Evaluation of skin scrapings confirmed the presence of live Sarcoptes scabiei. Both wombats were treated with three 100‐mL doses of moxidectin topically poured on to the dorsal backline approximately 7 days apart. Both animals showed improvement, with skin becoming clear of crusting and dermatitis, and no S. scabiei mites were present on either animal after 2 weeks. Here, we presented two clinical scenarios of sarcoptic mange in wombats that were successfully treated with three 100‐mL doses of moxidectin applied topically. We recommend this treatment be used where wombats can be identified and monitored throughout their recovery.
Sarcoptic mange is a debilitating disease affecting free‐living/wild bare‐nosed wombats (Vombatus ursinus). The disease causes thickening of the skin, pruritus, alopecia and deep fissures in the skin of infected animals, and ultimately death if left untreated. In Australia, there are approvals from the Australian Pesticides and Veterinary Medicines Authority to use moxidectin for treating sarcoptic mange in bare‐nosed wombats; however, few published literatures document the success of treatment regimens. Two adult male bare‐nosed wombats presented with dermatitis, erythema and crusting of the skin. Evaluation of skin scrapings confirmed the presence of live Sarcoptes scabiei. Both wombats were treated with three 100‐mL doses of moxidectin topically poured on to the dorsal backline approximately 7 days apart. Both animals showed improvement, with skin becoming clear of crusting and dermatitis, and no S. scabiei mites were present on either animal after 2 weeks. Here, we presented two clinical scenarios of sarcoptic mange in wombats that were successfully treated with three 100‐mL doses of moxidectin applied topically. We recommend this treatment be used where wombats can be identified and monitored throughout their recovery.
Wildlife care and rehabilitation are undertaken by thousands of volunteers throughout Australia every year. Bare-nosed (Vombatus ursinus) and southern hairy-nosed wombats (Lasiorhinus latifrons) regularly come into care, with the demands on wombat carers and the numbers of wombats increasing. Understanding the burdens placed on wombat carers and rehabilitators will provide information to wildlife managers to assess the risks to wombats and document the concerns of wildlife carers. Data were collected via an online quantitative and qualitative survey using Qualtrics. The survey was distributed through Facebook groups to wombat carers and rehabilitators and received 22 responses. The survey confirmed that caring for wombats is time-consuming and expensive, particularly when raising wombat joeys. Both adult and juvenile wombats were brought into care; the most common reasons were vehicle collisions, sarcoptic mange, and injuries resulting from dog or wombat attacks. Despite the significant financial and mental health costs to wombat carers, in most cases, carers thought young wombats that came into care were successfully rehabilitated and re-introduced into their natural habitat. Our study provides insights into the issues facing wombats, the people that care for wombats, and the wider carer sector.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.